
INBIOGEN CO.,Ltd — Investor Relations & Filings
INBIOGEN is a life sciences company that provides Virtual Biotech Assistance to international biotechnology companies, pharmaceutical firms, and research organizations. The company specializes in harnessing data mining to deliver a range of services, including bioinformatics, custom data curation, database development, and the creation of operational platforms. Core bioinformatics offerings encompass data analysis, protein modeling, homology searches, phylogeny, and immunogenicity analysis. Additionally, INBIOGEN provides virtual research, marketing assistance, and web development services. The company focuses on creating customized, value-added solutions through a team of experienced scientists and bioinformatics professionals to help clients address challenges and utilize online resources effectively.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| [기재정정]주주총회소집결의 | 2026-05-21 | Korean | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| 주주총회소집결의 | 2026-04-20 | Korean | |
| 주주명부폐쇄기간또는기준일설정 | 2026-04-20 | Korean | |
| 정기주주총회결과 | 2026-03-31 | Korean | |
| [기재정정]사업보고서 (2025.12) | 2026-03-31 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46712534 | [기재정정]주주총회소집결의 | 2026-05-21 | Korean | ||
| 46366899 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 34689562 | 주주총회소집결의 | 2026-04-20 | Korean | ||
| 34689561 | 주주명부폐쇄기간또는기준일설정 | 2026-04-20 | Korean | ||
| 33119961 | 정기주주총회결과 | 2026-03-31 | Korean | ||
| 33119914 | [기재정정]사업보고서 (2025.12) | 2026-03-31 | Korean | ||
| 33119874 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-31 | Korean | ||
| 33014956 | 감사보고서제출 | 2026-03-23 | Korean | ||
| 33014448 | 사업보고서 (2025.12) | 2026-03-23 | Korean | ||
| 32953517 | 주주총회소집공고 | 2026-03-16 | Korean | ||
| 32953393 | [기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경 | 2026-03-16 | Korean | ||
| 32953388 | 주주총회소집결의 | 2026-03-16 | Korean | ||
| 32848596 | 임시주주총회결과 | 2026-02-27 | Korean | ||
| 19466234 | 매출액또는손익구조30%(대규모법인은15%)이상변경 | 2026-02-12 | Korean | ||
| 19466226 | [기재정정]주주총회소집결의 | 2026-02-12 | Korean | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Asarina Pharma AB
A biotechnology company in liquidation, formerly focused on…
|
ASAP | SE | Professional, scientific and te… |
|
Atara Biotherapeutics, Inc.
Develops off-the-shelf allogeneic T-cell immunotherapies fo…
|
ATRA | US | Professional, scientific and te… |
|
ATUM CO., LTD.
An integrated biologics development partner offering servic…
|
355690 | KR | Professional, scientific and te… |
|
AUREKA LIMITED
Accelerates drug discovery and development using AI and com…
|
AKA | AU | Professional, scientific and te… |
|
Avalo Therapeutics, Inc.
Clinical-stage biotech developing treatments for immune-med…
|
AVTX | US | Professional, scientific and te… |
|
Avalyn Pharma Inc.
Developing innovative inhaled therapies for rare respirator…
|
AVLN | US | Professional, scientific and te… |
|
Azenta, Inc.
Offers sample management, storage, and multiomics solutions…
|
AZTA | US | Professional, scientific and te… |
|
Baijin Life Science Holdings Limited
An investment holding company operating in biopharmaceutica…
|
1466 | HK | Professional, scientific and te… |
|
BCAL DIAGNOSTICS LIMITED
Developing a non-invasive blood test for early breast cance…
|
BDX | AU | Professional, scientific and te… |
|
BEBETTER MED INC.
Develops small molecule therapeutics for oncology, metaboli…
|
688759 | CN | Professional, scientific and te… |
INBIOGEN CO.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16235/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16235 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16235 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16235 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16235}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for INBIOGEN CO.,Ltd (id: 16235)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.